Pharma News

Aurobindo Pharma receive US FDA approval for manufacture and market entacapone tablets and azithromycin for injection

  • Posted on: 29 June 2015
  • By: Shalini.Sharma

Aurobindo Pharma got final approvals from the US FDA of azithromycin for injection USP, 500mg /vial and entacapone tablets. Azithromycin for injection USP, 500mg/vial is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Zithromax (azithromycin for injection) 500mg/vial of Pfizer, Inc. Azithromycin for injection, USP is a macrolide antibacterial drug indicated for the treatment of patients with infections caused by susceptible strains of the designated microorganisms in the conditions such as community-acquired pneumonia and pelvic inflammatory disease.

Breakthrough arthritis treatment developed by Aus researchers

  • Posted on: 29 June 2015
  • By: PharmaTutor News

Australian researchers have developed a breakthrough vaccine-style therapeutic approach to treat rheumatoid arthritis, a debilitating disease affecting over 450,000 people in the country. Lead researcher Ranjeny Thomas from the University of Queensland's Diamantina Institute said results from the phase one clinical trial demonstrate the new treatment is safe and effective in supressing the immune response.

Single shot of Anti-Malaria Drug Immunize Against Malaria

  • Posted on: 27 June 2015
  • By: Shalini.Sharma

The research conducted by Dundee University, Scotland explained that the newly developed drug could work well against parasites resistant to current treatments of the mosquito-borne disease. Researchers  discovered a new compound, DDD107498 to treat malaria in a single dose, protects people from the disease and prevent the transmission of infection. The research is printed  in the journal 'Nature'.

IPC launches android mobile application for ADR reporting

  • Posted on: 27 June 2015
  • By: Shalini.Sharma

Shri B P Sharma, Secretary Health, Ministry of Health & Family Welfare and Chairman, Indian Pharmacopoeia Commission, Government of India launched an Android Mobile Applications for Adverse Drug Reactions (ADRs) reporting facility to the stakeholders of Pharmacovigilance Programme of India (PvPI). The mobile application for ADR reporting was specifically designed to facilitate the needs of the IPC, to ensure hassle free ADR reporting for the stakeholders. The mobile application is expected to provide a platform for the private healthcare professionals to report ADRs to safeguard and enhance public health by ensuring the safety, efficacy and quality of drugs.

Andhra Pradesh government launches ‘e-Aushadini’ app

  • Posted on: 26 June 2015
  • By: Shalini.Sharma

The Andhra Pradesh government has launched a new software application ‘e-Aushadini’ to manage stocks of various drugs in government hospitals. The main aim of 'e-Aushadini' is to ascertain the needs of various district drug warehouses such that all the required materials/drugs are constantly available to be supplied to the user district drug warehouses without delay.

1mg.com acquires Homeobuy.com; Major Expansion Plans on the Cards

  • Posted on: 25 June 2015
  • By: PharmaTutor News

(NewsVoir); Aggressively moving towards its expansion plans, 1mg.com - India’s leading m-health platform that has also been operating the largest e-Pharmacy marketplace in the country, announced today that it has decided to expand the scope of its platform and is entering the alternate medicine space (AYUSH categories) through the acquisition of www. Homeobuy.com. Homeobuy is a web platform for homeopathy medicines. With this acquisition, 1mg will re-brand the website to www. 1mgAyush.com and make Homeopathic & Ayurvedic medicines available to customers in New Delhi.

Pages